文献速递眼底病与葡萄膜炎

基于智能手机的离线人工智能系统在社区糖尿病视网膜病变筛查中的诊断准确性

Diagnostic Accuracy of Community-Based Diabetic Retinopathy Screening With an Offline Artificial Intelligence System on a Smartphone.
PubMed 文献 · JAMA Ophthalmol · 2019-01-01

这项前瞻性、横断面、基于人群的研究于2018年8月至9月在印度孟买由市政公司管理的药房纳入糖尿病患者,由经过最低限度培训的卫生工作者使用智能手机非散瞳眼底相机拍摄三个视野,比较离线人工智能系统与眼科医生对同一批图像诊断需转诊糖尿病视网膜病变的准确性。人工智能系统诊断需转诊糖尿病视网膜病变的敏感度为100.0%(95%CI 78.2%-100.0%),特异度为88.4%(95%CI 83.2%-92.5%)。作者认为试点结果显示出离线人工智能系统用于社区筛查的前景,但需要更大样本量的研究将结果推广到一般人群筛查。

要点

  • 离线人工智能系统诊断需转诊糖尿病视网膜病变的敏感度为100.0%(95%CI 78.2%-100.0%),特异度为88.4%(95%CI 83.2%-92.5%)。
  • 诊断任何糖尿病视网膜病变的敏感度为85.2%(95%CI 66.3%-95.8%),特异度为92.0%(95%CI 97.1%-95.4%)。
  • 作者认为该试点结果显示出离线人工智能系统用于社区筛查的前景,但需要更大样本量的研究将结果推广到一般人群筛查。

核心结论

  • 这些试点研究结果显示,使用基于智能手机的眼底相机和离线人工智能系统进行社区需转诊糖尿病视网膜病变筛查具有前景。
  • 使用人工智能可使眼科医生服务不可及的偏远地区能够进行需转诊糖尿病视网膜病变筛查。
  • 本研究是在一家提供初级人群治疗服务的药房就诊的糖尿病患者中进行的;然而,可能需要一项更大样本量的研究将结果推广到一般人群筛查。

研究设计与样本

  • 这是一项前瞻性、横断面、基于人群的研究,于2018年8月至2018年9月进行。
  • 纳入在特定日期就诊于印度孟买大孟买市政公司管理的各药房的糖尿病患者。
  • 由经过最低限度培训的卫生工作者使用智能手机非散瞳眼底相机拍摄眼底三个视野(后极部、鼻侧和颞侧)。
  • 图像由眼科医生和人工智能系统分别分析。

主要发现

  • 在药房就诊的255例患者中,231例(90.6%)同意接受糖尿病视网膜病变筛查。
  • 未参与的主要原因是不愿意等待筛查和散瞳后出现的视力模糊。
  • 18例患者的图像被眼科医生判定为不可分级,因此被排除。
  • 在剩余参与者(110例女性[51.6%]和103例男性[48.4%];平均[SD]年龄53.1[10.3]岁)中,离线人工智能系统诊断需转诊糖尿病视网膜病变的敏感度为100.0%(95%CI 78.2%-100.0%),特异度为88.4%(95%CI 83.2%-92.5%)。
  • 与眼科医生使用同一批图像分级相比,离线人工智能系统诊断任何糖尿病视网膜病变的敏感度为85.2%(95%CI 66.3%-95.8%),特异度为92.0%(95%CI 97.1%-95.4%)。

关键数值与推荐

  • 需转诊糖尿病视网膜病变定义为任何比轻度糖尿病视网膜病变更严重的视网膜病变,伴或不伴糖尿病黄斑水肿。
  • 人工智能系统诊断需转诊糖尿病视网膜病变的敏感度为100.0%(95%CI 78.2%-100.0%),特异度为88.4%(95%CI 83.2%-92.5%)。
  • 人工智能系统诊断任何糖尿病视网膜病变的敏感度为85.2%(95%CI 66.3%-95.8%),特异度为92.0%(95%CI 97.1%-95.4%)。

临床怎么用

  • 作者认为,使用人工智能可使眼科医生服务不可及的偏远地区能够进行需转诊糖尿病视网膜病变筛查。
  • 作者指出,可能需要一项更大样本量的研究将结果推广到一般人群筛查。

局限性

  • 这是一项试点研究。
  • 作者指出,可能需要一项更大样本量的研究将结果推广到一般人群筛查。
  • 本研究是在一家提供初级人群治疗服务的药房就诊的糖尿病患者中进行的。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Offline automated analysis of retinal images on a smartphone may be a cost-effective and scalable method of screening for diabetic retinopathy; however, to our knowledge, assessment of such an artificial intelligence (AI) system is lacking. OBJECTIVE: To evaluate the performance of Medios AI (Remidio), a proprietary, offline, smartphone-based, automated system of analysis of retinal images, to detect referable diabetic retinopathy (RDR) in images taken by a minimally trained health care worker with Remidio Non-Mydriatic Fundus on Phone, a smartphone-based, nonmydriatic retinal camera. Referable diabetic retinopathy is defined as any retinopathy more severe than mild diabetic retinopathy, with or without diabetic macular edema. DESIGN, SETTING, AND PARTICIPANTS: This prospective, cross-sectional, population-based study took place from August 2018 to September 2018. Patients with diabetes mellitus who visited various dispensaries administered by the Municipal Corporation of Greater Mumbai in Mumbai, India, on a particular day were included. INTERVENTIONS: Three fields of the fundus (the posterior pole, nasal, and temporal fields) were photographed. The images were analyzed by an ophthalmologist and the AI system. MAIN OUTCOMES AND MEASURES: To evaluate the sensitivity and specificity of the offline automated analysis system in detecting referable diabetic retinopathy on images taken on the smartphone-based, nonmydriatic retinal imaging system by a health worker. RESULTS: Of 255 patients seen in the dispensaries, 231 patients (90.6%) consented to diabetic retinopathy screening. The major reasons for not participating were unwillingness to wait for screening and the blurring of vision that would occur after dilation. Images from 18 patients were deemed ungradable by the ophthalmologist and hence were excluded. In the remaining participants (110 female patients [51.6%] and 103 male patients [48.4%]; mean [SD] age, 53.1 [10.3] years), the sensitivity and specificity of the offline AI system in diagnosing referable diabetic retinopathy were 100.0% (95% CI, 78.2%-100.0%) and 88.4% (95% CI, 83.2%-92.5%), respectively, and in diagnosing any diabetic retinopathy were 85.2% (95% CI, 66.3%-95.8%) and 92.0% (95% CI, 97.1%-95.4%), respectively, compared with ophthalmologist grading using the same images. CONCLUSIONS AND RELEVANCE: These pilot study results show promise in the use of an offline AI system in community screening for referable diabetic retinopathy with a smartphone-based fundus camera. The use of AI would enable screening for referable diabetic retinopathy in remote areas where services of an ophthalmologist are unavailable. This study was done on patients with diabetes who were visiting a dispensary that provides curative services to the population at the primary level. A study with a larger sample size may be needed to extend the results to general population screening, however.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Natarajan S, Jain A, Krishnan R, et al. Diagnostic Accuracy of Community-Based Diabetic Retinopathy Screening With an Offline Artificial Intelligence System on a Smartphone. JAMA Ophthalmol. 2019. PMID: 31393538. doi:10.1001/jamaophthalmol.2019.2923

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。